Home
Conditions
ANCA-associated Vasculitis

Clinical trial condition

ANCA-associated Vasculitis

Explore clinical trials studying ANCA-associated Vasculitis. Study availability and eligibility vary by location and protocol.

18 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

ANCA-associated Vasculitis trial results

Recruiting

Studies of the Natural History, Pathogenesis, and Outcome of Idiopathic Systemic Vasculitis

NCT02257866

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, +26 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

The BCMA/CD19 Dual Targeted CAR-T Cell in Participants With Autoimmune Kidney Diseases

NCT06285279

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +22 more
Locations: Jinling Hospital Nanjing, Jiangsu, China

View Trial Details

Recruiting

Biocollection of Patients With ANCA Associated Vasculitis

NCT05364892

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: CHRU de Brest - Service de rhumatologie Brest, France

View Trial Details

Recruiting

(68)Ga-FAPI PET/CT in Patients With ANCA-associated Vasculitis

NCT07151521

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
Locations: Ruiiin Hospital Shanghai JiaoTong University School of Medicine Shanghai, China

View Trial Details

Recruiting

BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases

NCT06794008

Conditions: ANCA-associated Vasculitis, Acquired Thrombotic Thrombocytopenic Purpura, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +62 more
Locations: Department of Rheumatology and Immunology, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of ANCA-associated Vasculitis (TTCAZAREM)

NCT05965284

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +9 more
Locations: Peking Union Medical College Hospital Beijing, Beijing Municipality, China

View Trial Details

Not Yet Recruiting

Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies

NCT07251179

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Antiphospholipid Syndrome, +15 more
Locations: Hôpitaux Universitaires de Strasbourg Strasbourg, France

View Trial Details

Not Yet Recruiting

Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV

NCT06986018

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +14 more
Locations: Peking University People's Hospital Beijing, China

View Trial Details

Not Yet Recruiting

UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune Diseases

NCT06978738

Conditions: ANCA-associated Vasculitis, Anemia, Anemia, Hemolytic, +36 more
Locations: Changzhou No.2 People's Hospital Changzhou, China

View Trial Details

Completed

Biosimilars of Rituximab in ANCA-associated Vasculitis Compared to the Originator

NCT05716334

Conditions: ANCA-associated Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
Locations: University of Calgary Calgary, Alberta, Canada

University of Alberta Edmonton, Alberta, Canada

University of British Columbia (Vancouver Coastal Health Authority) Vancouver, British Columbia, Canada

St Joseph's Healthcare Hamilton (McMaster University) Hamilton, Ontario, Canada

View Trial Details

ANCA-associated Vasculitis

ANCA-associated Vasculitis trial results

Related conditions